Physician profile
Eric S Heaps
NPI 1154751782
$7,676.03
in general payments reported to CMS, 2019-2025
13 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $233 · 2021: $1,131 · 2022: $2,337 · 2023: $305 · 2024: $1,265 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Travel and Lodging: $1,465 · Entertainment: $91.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.49 |
| Travel and Lodging | $1,465.38 |
| Entertainment | $91.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $4,296.66 | 2021-2025 | Acuvue |
| Coopervision INC. | $1,699.43 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $417.60 | 2019-2020 | |
| Horizon Therapeutics Plc | $246.07 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $219.96 | 2020-2022 | |
| Alcon Vision LLC | $166.75 | 2021-2025 | Acrysof Iq Vivity, Precision 1 |
| Amgen INC. | $118.89 | 2025 | Tepezza |
| Dompe US, INC. | $116.61 | 2025 | Oxervate |
| Optovue, INC. | $107.91 | 2019 | |
| Optos, INC. | $91.34 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $90.71 | 2024 | |
| Alcon Research LLC | $86.86 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Heaps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.